Tumor necrosis factor: A master-regulator of leukocyte movement

Immunology Today

Volumn 21, Issue 3, 2000, Pages 110-113

  Sedgwick, Jonathon D ^a   Riminton, D Sean ^b   Cyster, Jason G ^c   Körner, Heinrich ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P75; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DEMYELINATION; ENDOTHELIUM CELL; GRANULOMA; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; LYMPHOCYTE HOMING; LYMPHOID TISSUE; MACROPHAGE ACTIVATION; MICROGLIA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY; T LYMPHOCYTE;

ANIMALS; CELL MOVEMENT; CHEMOKINES; HEMATOPOIESIS; LEUKOCYTES; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033996188     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(99)01573-X     Document Type: Short Survey

References (31)

1. Körner H.et al. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organisation of lymphoid tissue. Eur. J. Immunol. 27:1997;2600-2609.
2. Riminton D.S.et al. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient but not TNF-deficient mice. J. Exp. Med. 187:1998;1517-1528.
3. Körner H.et al. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1997;1585-1590.
4. Cook M.et al. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J. Exp. Med. 188:1998;1503-1510.
5. Bean A.G.D.et al. Structural deficiencies in granuloma formation in tumor necrosis factor gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin. J. Immunol. 162:1999;3504-3511.
6. Smyth M.J.et al. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1998;1611-1619.
7. Ngo V.N.et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:1999;403-412.
8. Feldmann M.et al. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:1996;397-440.
9. Cope A.P. Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 10:1998;669-676.
10. Kollias G.et al. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169:1999;175-194.
11. Bazzoni F., Beutler B. The tumour necrosis factor ligand and receptor families. New Engl. J. Med. 334:1996;1717-1725.
12. Ruuls S.R., Sedgwick J.D. Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models. Am. J. Hum. Genet. 65:1999;294-301.
13. Mackay F.et al. Cytotoxic activities of recombinant soluble murine lymphotoxin-α and lymphotoxin-αβ complexes. J. Immunol. 159:1997;3299-3310.
14. Fu Y.X., Chaplin D.D. Development and maturation of secondary lymphoid tissue. Annu. Rev. Immunol. 17:1999;399-433.
15. Willenborg D.O.et al. Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Res. Immunol. 149:1998;804-810.
16. Hjelmstrom P.et al. Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis. Res. Immunol. 149:1998;794-804.
17. Körner H.et al. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J. Exp. Med. 191:2000;61-76.
18. Endres R.et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J. Exp. Med. 189:1999;159-168.
19. Benveniste E.N., Benos D.J. TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J. 9:1995;1577-1584.
20. Riminton, D.S. and Sedgwick, J.D. in Curr. Dir. Autoimmun. (Fathman, C.G., ed.), Karger (in press).
21. Sedgwick J.D., Hickey W.F. Keane R.W., Hickey W.F. Immunology of the Nervous System. 1997;364-418 Oxford University Press.
22. Gregersen R.et al. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cerebral Blood Flow Metab. 20:2000;53-65.
23. Gunn M.D.et al. A B-cell homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor 1. Nature. 391:1998;799-803.
24. Ransohoff R.M., Tani M. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation. Trends Neurosci. 21:1998;154-159.
25. Tessier P.A.et al. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J. Immunol. 159:1997;3595-3602.
26. Czermak B.J.et al. In vitro and in vivo dependency of chemokine generation on C5a and TNF-α J. Immunol. 162:1999;2321-2325.
27. Barna B.P.et al. Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J. Neuroimmunol. 50:1994;101-107.
28. Pakala S.V.et al. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J. Exp. Med. 189:1999;1053-1062.
29. Tkachuk M.et al. Crucial role of tumor necrosis factor receptor I expression on non-hematopoietic cells for B cell localization within the splenic white pulp. J. Exp. Med. 187:1998;469-477.
30. Maini R.N.et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 41:1998;1552-1563.
31. Moreland L.W. Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis. Rheum. Dis. Clin. North Am. 24:1998;579-591.